CVS Health Corporation (LON:0HRS)

London flag London · Delayed Price · Currency is GBP · Price in USD
75.19
-0.64 (-0.84%)
At close: Dec 5, 2025
29.34%
Market Cap 72.97B
Revenue (ttm) 291.39B
Net Income (ttm) 348.91M
Shares Out n/a
EPS (ttm) 0.28
PE Ratio 209.14
Forward PE 10.99
Dividend 2.03 (2.68%)
Ex-Dividend Date Oct 23, 2025
Volume 897
Average Volume 4,068
Open 76.72
Previous Close 75.83
Day's Range 75.19 - 77.13
52-Week Range 43.56 - 85.80
Beta 0.48
RSI 38.19
Earnings Date Feb 4, 2026

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1996
Employees 300,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HRS
Full Company Profile

Financial Performance

In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.

Financial numbers in USD Financial Statements

News

CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States

New report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities WOONSOCKET, R.I. , Dec. 5, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) ...

21 hours ago - PRNewsWire

CVS Health (CVS) Analyst Rating Update: Target Price Raised by Bernstein | CVS Stock News

CVS Health (CVS) Analyst Rating Update: Target Price Raised by Bernstein | CVS Stock News

22 hours ago - GuruFocus

Aetna expands initiatives to simplify experiences for health care professionals and patients

Bundling medical procedures and pharmaceutical medications into one prior authorization Implementing end-to-end generative AI capabilities into Aetna Health app HARTFORD, Conn. , Dec. 4, 2025 /PRNewsw...

1 day ago - PRNewsWire

2 Soaring Healthcare Stocks to Buy and Hold for a Decade

HCA Healthcare and CVS Health are firing on all cylinders.

2 days ago - The Motley Fool

CVS Accused Of Years Of Faulty Insulin Refills In $37.8 Million Settlement

Federal prosecutors on Tuesday said Jay Clayton , the U.S. attorney for the Southern District of New York, alleged that CVS Health Inc . (NYSE: CVS) engaged in a years-long pattern of improper billin...

2 days ago - Benzinga

CVS Health (CVS) Settles $37.76M Overbilling Allegations

CVS Health (CVS) Settles $37.76M Overbilling Allegations

3 days ago - GuruFocus

17 dividend-stock bargains from a value manager with a stellar track record

John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”

3 days ago - Market Watch

CVS Health to pay $37.76M in settlement for insulin pens claims

CVS Health settles $37.76M for overbilling government health programs on insulin pens. Read more here.

3 days ago - Seeking Alpha

CVS Settles Healthcare Fraud Allegations with $37.76M Payment

CVS Settles Healthcare Fraud Allegations with $37.76M Payment

3 days ago - GuruFocus

CVS to pay $37.8 million to settle claims over insulin pens

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients and then sought reimbursement from government healthcare programs, U.S. Attorney Jay Clayton in ...

3 days ago - Reuters

Cornerstone Community Development, Winterwood, CVS Health, and Community Organizations Announce the Prichard Centennial Residential Reveal and Next-Phase Preview

HUNTINGTON, W.Va. , Dec. 1, 2025 /PRNewswire/ -- Cornerstone Community Development, in cooperation with Winterwood, CVS Health® (NYSE: CVS) and other community organizations, invites the public and me...

4 days ago - PRNewsWire

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

4 days ago - Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

4 days ago - Benzinga

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS

Harrow, Inc. is experiencing explosive growth, driven by its success in branded pharmaceuticals, especially Vevye. Vevye, HROW's flagship dry eye drug, is projected to reach $100M in 2025 and $300M in...

4 days ago - Seeking Alpha

Forget CVS, Buy This Healthcare Stock Instead

This healthcare stock has struggled this year, but things are suddenly looking up.

7 days ago - The Motley Fool

CVS Health Delivers MBR Improvement: Is More Progress in the Cards?

CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.

7 days ago - Nasdaq

These outperforming stocks are still cheap heading into 2026

US stocks have been in a sharp uptrend over the past seven months, with the benchmark S&P 500 index currently up more than 35% versus its year-to-date low in April. Still, a handful of outperformers a...

8 days ago - Invezz

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)

CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

9 days ago - Nasdaq

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?

CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

9 days ago - Nasdaq

CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?

CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.

10 days ago - Nasdaq

Abortion pill makers brace for restrictions a year after Trump's election

Federal rules on the abortion pill mifepristone remain unchanged a year after President Donald Trump's election, but an FDA safety review has stirred new uncertainty. State enforcement and lawsuits ar...

10 days ago - CNBC

Curaechoice Selects CVS Caremark at its PBM

All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies ...

11 days ago - GlobeNewsWire

Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent

Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic ...

12 days ago - Seeking Alpha

CVS Health Corporation (CVS) Appoints J. David Joyner as Chair of the Board

CVS Health Corporation (CVS) Appoints J. David Joyner as Chair of the Board

15 days ago - GuruFocus

CVS Announces David Joyner as New Board Chair

CVS Announces David Joyner as New Board Chair

15 days ago - GuruFocus